Attenuating cardiovascular risk factors in patients with type 2 diabetes

American Family Physician

Volumn 62, Issue 12, 2000, Pages

  Garber, Alan J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIOXIDANT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CERIVASTATIN; CLOFIBRATE; COLESTIPOL; COLESTYRAMINE; COUMARIN ANTICOAGULANT; CYCLOSPORIN; CYCLOSPORIN A; DIGOXIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GANGLION BLOCKING AGENT; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVACON; NICOTINIC ACID; PRAVASTATIN; RESIN; SIMVASTATIN; STATIN; THIAZIDE DIURETIC AGENT; THYROXINE; UNINDEXED DRUG; VASOACTIVE AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG CHOICE; DRUG INDUCED DISEASE; DYSLIPIDEMIA; ENDOTHELIUM; EXERCISE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RISK FACTOR; SMOKING; SYNDROME X;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HOMOCYSTEINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPERTENSION; LIPOPROTEINS; PATIENT EDUCATION; RISK FACTORS; SMOKING CESSATION; TEACHING MATERIALS;

EID: 0034671138     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. The deadly quartet - The insulin resistance syndrome
2. Epidemiology of diabetic dyslipidemia
3. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
4. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
5. Atherosclerosis: Risk factors and the vascular endothelium
6. Endothelial dysfunction in coronary artery disease
7. Management of dyslipidemia in adults with diabetes
8. Dysfunction of vascular endothelium in diabetes mellitus
9. The oxidation hypothesis of atherosclerosis
10. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome
11. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
12. Banting lecture 1988. Role of insulin resistance in human disease
13. Insulin resistance and hypersecretion in obesity
14. Pathophysiology of insulin resistance in human disease
15. Medical hazards of obesity
16. Current views on obesity
17. Dyslipidaemia and obesity
18. Role of insulin resistance in human disease (syndrome X): An expanded definition
19. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study. 1971-1992. National Health and Nutrition Examination Survey
20. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn Study
21. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
22. Homocysteine vitamins, and cardiovascular disease
23. Vascular disease and lipids in diabetes
24. Management of dyslipidemia in adults with diabetes. Clinical Practice Recommendations 2000
25. Nutrition recommendations and principles for people with diabetes mellitus. Clinical Practice Recommendations 2000
26. Diabetes mellitus and exercise. Clinical Practice Recommendations 2000
27. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men
28. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL
29. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland
30. Vitamin E supplementation and cardiovascular events in high-risk patients
31. Aspirin therapy in diabetes
32. Management of dyslipidemia in adults with diabetes. American Diabetes Association: Clinical practice recommendations 1998
33. Detection and management of lipid disorders in diabetes. American Diabetes Association: Clinical practice recommendations 1996
34. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
35. Pharmacologic management of triglycerides
36. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
37. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38